Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorUlusoy, Onur Levent
dc.contributor.authorServer, Sadik
dc.contributor.authorYesilova, Murat
dc.contributor.authorInan, Nagihan
dc.date.accessioned2025-01-12T18:54:46Z
dc.date.available2025-01-12T18:54:46Z
dc.date.issued2024
dc.identifier.issn1318-2099
dc.identifier.issn1581-3207
dc.identifier.urihttps://doi.org/10.2478/raon-2024-0062
dc.identifier.urihttp://hdl.handle.net/11446/4971
dc.description.abstractBackground Whole-body positron emission tomography/magnetic resonance imaging (WB-PET/MRI) is increasingly used in the initial evaluation of oncology patients. The purpose of this study was to compare the diagnostic performance of WB MRI sequences, attenuation-corrected raw data positron-emission tomography (AC PET), and PET/MRI fused images to detect bone metastases.Patients and methods We included 765 consecutive oncologic patients who received WB-PET/MRI from between January 2017 and September 2023. The presence of bone metastases was assessed using the individual sequences by two radiologists. Interobserver agreement was calculated. A receiver operating characteristic (ROC) analysis was performed to assess the performance of each individual sequence and fused images.Results Interobserver agreement for the detection of bone metastases on all sequences ranged from good to very good. The reading of the combination of MRI sequences with PET images showed statistically significantly better performance than the reading of individual MRI sequences and PET component only. Contrast enhanced T1 W Volume-interpolated breath-hold examination (CE T1W VIBE) sequence superior to PET for the detection of bone metastasis, but the statistical significance was not as high as with T1W-PET and CE T1W-PET fused images. The highest performance was achieved by the fused CE T1W-PET images with sensitivity of 100%, specificity of 92%, PPV of 96%, and NPV of 100%.Conclusions The combination of these CE T1W VIBE sequences with PET images have the highest diagnostic performance in detecting bone metastases in oncologic patients. This sequence should be integrated in WB-PET/MRI acquisitions for initial staging of cancer.en_US
dc.language.isoengen_US
dc.publisherSciendoen_US
dc.relation.ispartofRadiology and Oncologyen_US
dc.identifier.doi10.2478/raon-2024-0062
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectbone metastasesen_US
dc.subjecthybrid imagingen_US
dc.subjectpositron-emission tomographyen_US
dc.subjectmagnetic resonance imagingen_US
dc.subjectF-18-Fluoride Peten_US
dc.subjectProstate-Canceren_US
dc.subjectFdg-Pet/Cten_US
dc.subjectScintigraphyen_US
dc.subjectBreasten_US
dc.subjectMrien_US
dc.subjectSpect/Cten_US
dc.subjectCten_US
dc.subjectDiseaseen_US
dc.subjectFusionen_US
dc.titleWhole-body PET/MRI to detect bone metastases: comparison of the diagnostic performance of the sequencesen_US
dc.typearticleen_US
dc.departmentDBÜen_US
dc.identifier.issue4en_US
dc.identifier.volume58en_US
dc.identifier.startpage494en_US
dc.identifier.endpage500en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Ulusoy, Onur Levent; Server, Sadik; Yesilova, Murat; Inan, Nagihan] Demiroglu Bilim Univ, Istanbul, Turkiye; [Ulusoy, Onur Levent; Server, Sadik; Inan, Nagihan] Florence Nigtingale Hosp, Dept Radiol, Istanbul, Turkiyeen_US
dc.identifier.pmid39608007en_US
dc.identifier.scopus2-s2.0-85211226048en_US
dc.identifier.wosWOS:001366976700012en_US
dc.authorscopusid7003954789
dc.authorscopusid57188633469
dc.authorscopusid59461208600
dc.authorscopusid15127460600


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster